367 related articles for article (PubMed ID: 23764392)
1. Regulation of mitochondrial fatty acid β-oxidation in human: what can we learn from inborn fatty acid β-oxidation deficiencies?
Bastin J
Biochimie; 2014 Jan; 96():113-20. PubMed ID: 23764392
[TBL] [Abstract][Full Text] [Related]
2. Bezafibrate increases very-long-chain acyl-CoA dehydrogenase protein and mRNA expression in deficient fibroblasts and is a potential therapy for fatty acid oxidation disorders.
Djouadi F; Aubey F; Schlemmer D; Ruiter JP; Wanders RJ; Strauss AW; Bastin J
Hum Mol Genet; 2005 Sep; 14(18):2695-703. PubMed ID: 16115821
[TBL] [Abstract][Full Text] [Related]
3. Effect of heat stress and bezafibrate on mitochondrial beta-oxidation: comparison between cultured cells from normal and mitochondrial fatty acid oxidation disorder children using in vitro probe acylcarnitine profiling assay.
Li H; Fukuda S; Hasegawa Y; Kobayashi H; Purevsuren J; Mushimoto Y; Yamaguchi S
Brain Dev; 2010 May; 32(5):362-70. PubMed ID: 19589653
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial fatty acid beta-oxidation in the human eye and brain: implications for the retinopathy of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.
Tyni T; Paetau A; Strauss AW; Middleton B; Kivelä T
Pediatr Res; 2004 Nov; 56(5):744-50. PubMed ID: 15347768
[TBL] [Abstract][Full Text] [Related]
5. Genetic and cellular modifiers of oxidative stress: what can we learn from fatty acid oxidation defects?
Olsen RK; Cornelius N; Gregersen N
Mol Genet Metab; 2013; 110 Suppl():S31-9. PubMed ID: 24206932
[TBL] [Abstract][Full Text] [Related]
6. Heat stress deteriorates mitochondrial beta-oxidation of long-chain fatty acids in cultured fibroblasts with fatty acid beta-oxidation disorders.
Li H; Fukuda S; Hasegawa Y; Purevsuren J; Kobayashi H; Mushimoto Y; Yamaguchi S
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(20):1669-72. PubMed ID: 20207594
[TBL] [Abstract][Full Text] [Related]
7. Mutation analysis in mitochondrial fatty acid oxidation defects: Exemplified by acyl-CoA dehydrogenase deficiencies, with special focus on genotype-phenotype relationship.
Gregersen N; Andresen BS; Corydon MJ; Corydon TJ; Olsen RK; Bolund L; Bross P
Hum Mutat; 2001 Sep; 18(3):169-89. PubMed ID: 11524729
[TBL] [Abstract][Full Text] [Related]
8. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency.
Stanley CA
Adv Pediatr; 1987; 34():59-88. PubMed ID: 3318304
[TBL] [Abstract][Full Text] [Related]
9. Fatty acid oxidation disorders: maternal health and neonatal outcomes.
Rector RS; Ibdah JA
Semin Fetal Neonatal Med; 2010 Jun; 15(3):122-8. PubMed ID: 19926542
[TBL] [Abstract][Full Text] [Related]
10. Disorders of mitochondrial fatty acyl-CoA beta-oxidation.
Wanders RJ; Vreken P; den Boer ME; Wijburg FA; van Gennip AH; IJlst L
J Inherit Metab Dis; 1999 Jun; 22(4):442-87. PubMed ID: 10407780
[TBL] [Abstract][Full Text] [Related]
11. PPARs as therapeutic targets for correction of inborn mitochondrial fatty acid oxidation disorders.
Djouadi F; Bastin J
J Inherit Metab Dis; 2008 Apr; 31(2):217-25. PubMed ID: 18392740
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of mitochondrial fatty acid oxidation defects.
Duran M; Bruinvis L; Ketting D; Dorland L
Padiatr Padol; 1993; 28(1):19-25. PubMed ID: 8446424
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial fatty acid oxidation disorders and cyclic vomiting syndrome.
Rinaldo P
Dig Dis Sci; 1999 Aug; 44(8 Suppl):97S-102S. PubMed ID: 10490047
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial fatty-acid oxidation disorders.
Kompare M; Rizzo WB
Semin Pediatr Neurol; 2008 Sep; 15(3):140-9. PubMed ID: 18708005
[TBL] [Abstract][Full Text] [Related]
15. Fatty acid oxidation disorders.
Rinaldo P; Matern D; Bennett MJ
Annu Rev Physiol; 2002; 64():477-502. PubMed ID: 11826276
[TBL] [Abstract][Full Text] [Related]
16. Food withdrawal lowers energy expenditure and induces inactivity in long-chain fatty acid oxidation-deficient mouse models.
Diekman EF; van Weeghel M; Wanders RJ; Visser G; Houten SM
FASEB J; 2014 Jul; 28(7):2891-900. PubMed ID: 24648546
[TBL] [Abstract][Full Text] [Related]
17. Analysis of carnitine esters by radio-high performance liquid chromatography in cultured skin fibroblasts from patients with mitochondrial fatty acid oxidation disorders.
Schmidt-Sommerfeld E; Bobrowski PJ; Penn D; Rhead WJ; Wanders RJ; Bennett MJ
Pediatr Res; 1998 Aug; 44(2):210-4. PubMed ID: 9702916
[TBL] [Abstract][Full Text] [Related]
18. Long-chain fatty acid oxidation during early human development.
Oey NA; den Boer ME; Wijburg FA; Vekemans M; Augé J; Steiner C; Wanders RJ; Waterham HR; Ruiter JP; Attié-Bitach T
Pediatr Res; 2005 Jun; 57(6):755-9. PubMed ID: 15845636
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial dysfunction in fatty acid oxidation disorders: insights from human and animal studies.
Wajner M; Amaral AU
Biosci Rep; 2015 Nov; 36(1):e00281. PubMed ID: 26589966
[TBL] [Abstract][Full Text] [Related]
20. Clinical and biological features at diagnosis in mitochondrial fatty acid beta-oxidation defects: a French pediatric study of 187 patients.
Baruteau J; Sachs P; Broué P; Brivet M; Abdoul H; Vianey-Saban C; Ogier de Baulny H
J Inherit Metab Dis; 2013 Sep; 36(5):795-803. PubMed ID: 23053472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
